Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
NCT01640522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 261
Last updated 2024-12-13
Summary
The purpose of this study is to test the efficacy of a collaborative care intervention to manage cancer-related symptoms and improve health related quality of life in patients diagnosed with hepatobiliary carcinoma.
Conditions
- Hepatocellular Carcinoma
- Primary Liver Cancer
- Bile Duct Cancer
- Pancreatic Cancer
- Gallbladder Cancer
- Colorectal Carcinoma
- Liver Metastases
Interventions
- OTHER
-
Collaborative Care
Collaborative care intervention to manage cancer-related symptoms
- OTHER
-
Enhanced usual Care
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Jennifer L Steel, Ph.D. · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer
NCT02200042 ·Status: TERMINATED ·Phase: PHASE3
-
Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract
NCT00201305 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
NCT02924376 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma
NCT02994251 ·Status: TERMINATED ·Phase: PHASE2
-
Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials
NCT05706974 ·Status: NOT_YET_RECRUITING
-
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
NCT00003907 ·Status: COMPLETED ·Phase: PHASE2
-
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
NCT00669136 ·Status: TERMINATED ·Phase: PHASE1
-
Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
NCT02232932 ·Status: UNKNOWN ·Phase: NA
-
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
NCT02254681 ·Status: TERMINATED ·Phase: PHASE2
-
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy
NCT04572633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
NCT06622057 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.
NCT04378023 ·Status: RECRUITING
-
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
NCT02626312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
NCT04561453 ·Status: TERMINATED
-
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
NCT06777316 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial
NCT07021534 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
NCT04919642 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
NCT05211323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment
NCT05328167 ·Status: COMPLETED ·Phase: PHASE2
-
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
NCT06501625 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
NCT02178280 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
NCT06806579 ·Status: RECRUITING
-
Molecular Profiling of Advanced Biliary Tract Cancers
NCT03419247 ·Status: WITHDRAWN ·Phase: NA
-
Advanced Therapies for Liver Metastases
NCT04622423 ·Status: RECRUITING
-
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases
NCT00465023 ·Status: COMPLETED ·Phase: NA